Skip to main content
Phreesia, Inc. (PHR)
NYSE: PHR · IEX Real-Time Price · USD
22.92
+0.27 (1.19%)
At close: Jul 19, 2024, 4:00 PM
22.91
-0.01 (-0.04%)
After-hours: Jul 20, 2024, 12:57 PM EDT

Phreesia Revenue

Phreesia had revenue of $373.67M in the twelve months ending April 30, 2024, with 23.98% growth year-over-year. Revenue in the quarter ending April 30, 2024 was $101.22M with 20.72% year-over-year growth. In the fiscal year ending January 31, 2024, Phreesia had annual revenue of $356.30M with 26.84% growth.

Revenue (ttm)
$373.67M
Revenue Growth
+23.98%
P/S Ratio
3.52
Revenue / Employee
$259,855
Employees
1,438
Market Cap
1.32B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jan 31, 2024356.30M75.39M26.84%
Jan 31, 2023280.91M67.68M31.74%
Jan 31, 2022213.23M64.56M43.42%
Jan 31, 2021148.68M23.89M19.15%
Jan 31, 2020124.78M24.90M24.92%
Jan 31, 201999.89M20.06M25.12%
Jan 31, 201879.83M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ANI Pharmaceuticals 517.46M
Arcus Biosciences 237.00M
Dynavax Technologies 236.15M
Gyre Therapeutics 140.62M
Immatics 80.95M
Vir Biotechnology 79.60M
Nurix Therapeutics 62.30M
Revenue Rankings

PHR News

More News